New SEC Form D filing
Therapeutic Neuromodulation Systems LLC, 2026-09-21
A new SEC Form D private-offering notice from Metairie, LA, a $5,000,000 filer-stated offering target in Biotech. The source filing is one click away.
What this filing says
Sells the Morph Device, an FDA cleared behind the ear nerve stimulator used to reduce opioid withdrawal symptoms.
Filed 2026-09-21Filed to raise $5,000,000First money in 2017-10-15Raised so far $1,709,500HQ (as filed) Metairie, LASector Biotech web-verified against the company’s own siteStage (inferred) EarlyCall status Late filing
Source linked the Form D on EDGAR↗Website verified themorphdevice.com↗Named in the filing 1 executive & director
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Westfield Fluid Controls, Inc., 2026-09-30, $1M, Lafayette, LA
- Navion Neurosciences Inc., 2026-09-22, $5.1M, Charlottesville, VA
- Royal & Pelham, Inc., 2026-09-15, $7.2M, New Orleans, LA
- Opus Medical Therapies, LLC, 2026-09-22, Smyrna, GA
- Therapeutic Neuromodulation Systems LLC, 2026-09-11, $5M, Metairie, LA
- Typewriter Therapeutics, Inc., 2026-09-21, $56.3M, Cambridge, MA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.